Economic And Outcomes Issues in Mental Health And Neurological DisordersMHB3 Cost-Effectiveness Evaluation of New Antipsychotics
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 1998 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.